newsfilter
← Latest News
GlobeNewswire·

Anaptys Announces Participation in Upcoming Investor Conferences

  • AnaptysBio executive team members will attend three upcoming investor conferences to discuss financial collaborations for Jemperli with GSK & Quimilza with Vanda.
  • President & CEO Daniel Faga will participate in a fireside chat at the UBS Global Biopharma Conference 2026 in London on November 17, 2026, at 4:40pm GMT.
  • CFO Chris Murphy will attend a fireside chat & one-on-one meetings at the Piper Sandler 38th Annual Healthcare Conference in New York on December 2, 2026, at 8:00am ET.
  • Daniel Faga will also present at a fireside chat during the 9th Annual Evercore Healthcare Conference in Miami on December 2, 2026, at 10:50am ET.
  • Live webcasts & replays lasting at least 30 days will be accessible via the investor section of the Anaptys website.
Company
AnaptysBio, Inc.
Keywords
Nasdaq:ANAB, AnaptysBio, Inc.